0.3% Gentamicin Eye Drops 10mL | Aminoglycoside Antibacterial Eye Solution

Gentamicine Eye Drops
  • Concentration: 0.3% Gentamicin (3 mg/ml)
  • Volume: 5ml or 10ml per bottle
  • Packaging: Sterile plastic dropper bottle, 1 bottle/box
  • Shelf Life: 24 months (unopened)

Click to add this item to cart.

Product Description

Product Name0.3% Gentamicin Eye Drops 10mL (Gentamicin Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.3% (3 mg/mL) Gentamicin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientGentamicin (Aminoglycoside Antibacterial Agent)
Pharmacological ClassAntibacterial Ophthalmic Agent (Aminoglycoside)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 2-4 hours initially, then reduced as directed.
PackagingSterile multi-dose dropper bottle (10mL) with tamper-evident seal
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Shelf Life24 months unopened; discard within 4 weeks of first opening

Product Overview

0.3% Gentamicin Eye Drops is a sterile ophthalmic solution containing 0.3% (3 mg/mL) gentamicin. It is an antibacterial eye drop used for the topical management of bacterial eye infections affecting the ocular surface.

0.3% Gentamicin Eye Drops 10mL: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

Before 0.3% Gentamicin Eye Drops 10mL is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.

  • Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
  • Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)
  • Gentamicin eye drops 0.3% are on the Model List for ocular infection WHO lists gentamicin eye drops 0.3% (gentamicin sulfate) for infectious blepharitis, classified in the Access group of the AWaRe framework. The Expert Committee has specified amikacin, kanamycin, netilmicin and tobramycin as therapeutic alternatives under the gentamicin square-box listing. WHO eEML — Gentamicin (ophthalmological)

Each point above is reproduced because it has a practical consequence for 0.3% Gentamicin Eye Drops 10mL: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

0.3% Gentamicin Eye Drops 10mL — Supply Parameters

Product Name0.3% Gentamicin Eye Drops 10mL (Gentamicin Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.3% (3 mg/mL) Gentamicin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientGentamicin (Aminoglycoside Antibacterial Agent)
Pharmacological ClassAntibacterial Ophthalmic Agent (Aminoglycoside)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 2-4 hours initially, then reduced as directed.
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Therapeutic groupOphthalmic — Ophthalmic
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for 0.3% Gentamicin Eye Drops 10mL follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
  • Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

The legal manufacturer named on every document for 0.3% Gentamicin Eye Drops 10mL is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.

0.3% Gentamicin Eye Drops 10mL is presented here against ophthalmic preparations used in WHO and MSF eye-care protocols. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Frequently Asked Questions

What pack size is available for 0.3% Gentamicin Eye Drops 10mL?

Standard commercial packaging for this line is Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.

What documentation comes with a shipment of 0.3% Gentamicin Eye Drops 10mL?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening.

Does the batch documentation for 0.3% Gentamicin Eye Drops 10mL support a registration filing?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which ophthalmic anti-infectives are on the WHO Model List?

Gentamicin eye drops 0.3% (for infectious blepharitis) and ofloxacin eye drops 0.3% (infectious keratitis, with the indication extended to conjunctivitis in 2021). Amikacin, kanamycin, netilmicin and tobramycin are specified as therapeutic alternatives to gentamicin.

Do you supply preservative-free eye drops?

We can supply both preserved and preservative-free presentations depending on the product and your market requirement. Specify the preservative system on your enquiry.

Related Ophthalmic Products

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.

Request a Quotation for 0.3% Gentamicin Eye Drops 10mL

Tell us the monograph, pack size and quantity required for 0.3% Gentamicin Eye Drops 10mL 10mL, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products